GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxart Inc (STU:NB11) » Definitions » Shiller PE Ratio

Vaxart (STU:NB11) Shiller PE Ratio : (As of Jun. 21, 2024)


View and export this data going back to . Start your Free Trial

What is Vaxart Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vaxart Shiller PE Ratio Historical Data

The historical data trend for Vaxart's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxart Shiller PE Ratio Chart

Vaxart Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Vaxart Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vaxart's Shiller PE Ratio

For the Biotechnology subindustry, Vaxart's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxart's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxart's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vaxart's Shiller PE Ratio falls into.



Vaxart Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Vaxart's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Vaxart's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.129/131.7762*131.7762
=-0.129

Current CPI (Mar. 2024) = 131.7762.

Vaxart Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -2.348 100.560 -3.077
201409 -1.707 100.428 -2.240
201412 1.695 99.070 2.255
201503 0.305 99.621 0.403
201506 -5.391 100.684 -7.056
201509 -1.666 100.392 -2.187
201512 -1.717 99.792 -2.267
201603 -1.383 100.470 -1.814
201606 -1.762 101.688 -2.283
201609 -2.548 101.861 -3.296
201612 -2.503 101.863 -3.238
201703 -1.131 102.862 -1.449
201706 -1.469 103.349 -1.873
201709 -1.292 104.136 -1.635
201712 -0.837 104.011 -1.060
201803 0.397 105.290 0.497
201806 -1.061 106.317 -1.315
201809 -0.788 106.507 -0.975
201812 -0.607 105.998 -0.755
201903 -0.159 107.251 -0.195
201906 -0.345 108.070 -0.421
201909 -0.291 108.329 -0.354
201912 -0.117 108.420 -0.142
202003 -0.018 108.902 -0.022
202006 -0.107 108.767 -0.130
202009 -0.068 109.815 -0.082
202012 -0.107 109.897 -0.128
202103 -0.118 111.754 -0.139
202106 -0.108 114.631 -0.124
202109 -0.119 115.734 -0.135
202112 -0.150 117.630 -0.168
202203 -0.182 121.301 -0.198
202206 -0.218 125.017 -0.230
202209 -0.232 125.227 -0.244
202212 -0.170 125.222 -0.179
202303 -0.177 127.348 -0.183
202306 -0.148 128.729 -0.152
202309 -0.103 129.860 -0.105
202312 -0.110 129.419 -0.112
202403 -0.129 131.776 -0.129

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vaxart  (STU:NB11) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Vaxart Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Vaxart's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vaxart (STU:NB11) Business Description

Traded in Other Exchanges
Address
170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Vaxart (STU:NB11) Headlines

No Headlines